Premium Information is available for this item - Upgrade for $1 a day
6505-00-092-3013
Usp Alumina And Magnesia Oral Suspension
6505000923013 000923013 MAALOX SUSPENSION MAALOX NDC00067-0330-56
May 2023
9
Marketplace 6505-00-092-3013
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-092-3013 5+ Documents (More...)
And Magnesia Oral Suspension 5513Usp Alumina And Magnesia Oral Suspension6505010895513 010895513 MAALOX
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-092-3013 Usp Alumina And Magnesia Oral Suspension
MAALOX 400+400MG A'40 TBL.
NO. 2 TABLETS MAALOX NO. 2 NDC00067-0337-67 Managed by United States NSN Created on 28 Mar 1967 Data
MAALOX 40 MG A'20 TBL.
NO. 2 TABLETS MAALOX NO. 2 NDC00067-0337-67 Managed by United States NSN Created on 28 Mar 1967 Data
MAALOX ZAWIESINA 15ML A'30 SASZ- 5909990225330 Managed by Poland NSN Created on 24 Oct 2008 Data Last
NO. 2 TABLETS MAALOX NO. 2 NDC00067-0337-67 Managed by United States NSN Created on 28 Mar 1967 Data
THERAPEUTIC CONCENTRATE MAALOX TC NDC00067-0334-65 NDC00067-0334-75 Managed by United States NSN Created
6505-00-092-3631 6505-00-092-3631 6505-01-089-5513 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-092-3013
Restrictions 6505-00-092-3013
6505-00-092-3013 is a Usp Alumina And Magnesia Oral Suspension that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-092-3013
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-092-3013
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-092-3013
- Part Number
- Manufacturer
- Status
- NDC00067-0330-56
- Manufacturer
- 04518 - Aventis Pharmaceuticals Products (Active)
- Primary Buy
- Primary Buy
- MAALOX SUSPENSION
- 04518 - Aventis Pharmaceuticals Products (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- MAALOX
- 04518 - Aventis Pharmaceuticals Products (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-092-3013
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 45.000 Milligrams Aluminum Hydroxide Per Milliliter And 40.000 Milligrams Magnesium Hydroxide Per Milliliter
- Administration [CSGS]
- Oral
- Flavor [ALJH]
- Any Acceptable
- Supplementary Features [SUPP]
- Medsep Item For Dod,Rorer
- Primary Container Content Quantity [CRLK]
- 30.000 Milliliters
- Primary Container Quantity Per Secondary Container [CRXL]
- Cup,Patient 10
- Primary Container Type [CQCT]
- Cup,Patient
- Secondary Container Type [CQGK]
- Tray
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Special Features [FEAT]
- With Sodium 2.5 Mg Per 5 Ml
- Total Primary Container Quantity [CSCW]
- 100
- Total Secondary Container Quantity [CSCX]
- 10
Management Data 6505-00-092-3013
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1984
- Veterans Administration (VA)
- BX
- Subscribe
- BX
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Ea
- 00000000100EA
- K
NATO Stock Numbers Related to 6505-00-092-3013
Freight Information 6505-00-092-3013
6505-00-092-3013 has freight characteristics.. 6505-00-092-3013 has a variance between NMFC and UFC when transported by rail and the description should be consulted.